Cy­to­ki­net­ics

Last updated: October 28, 2025
CEO Robert I. Blum
CEO Robert I. Blum
Country: USA | Funding: $2.4B (+)

Website: https://cytokinetics.com/

Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.




Competitors